AI
The startup develops a nano diagnostics technology that utilizes artificial intelligence to enhance the precision of liquid biopsies for early cancer detection through prenatal tests. This technology enables timely surgical interventions by accurately identifying cancer at its initial stages, improving patient outcomes.
Updated 18 months ago
Funding
$3.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a nano diagnostics technology that utilizes artificial intelligence to enhance the precision of liquid biopsies for early cancer detection through prenatal tests. This technology enables timely surgical interventions by accurately identifying cancer at its initial stages, improving patient outcomes.